Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Association between apolipoprotein E genotype, serum lipids, and colorectal cancer in Brazilian individuals

Full text
Author(s):
Souza, D. R. S. [1] ; Nakazone, M. A. [1] ; Pinhel, M. A. S. [1] ; Alvares, R. M. [1] ; Monaco, A. C. [1] ; Pinheiro, A. [1] ; Barros, C. F. D. C. [1] ; Cury, P. M. [2] ; Cunrath, G. S. [3] ; Netinho, J. G. [3]
Total Authors: 10
Affiliation:
[1] Fac Med Sao Jose Rio Preto, Dept Biol Mol, BR-15090000 Sao Jose Do Rio Preto - Brazil
[2] Fac Med Sao Jose Rio Preto, Dept Patol & Med Legal, BR-15090000 Sao Jose Do Rio Preto - Brazil
[3] Fac Med Sao Jose Rio Preto, Dept Cirurgia, BR-15090000 Sao Jose Do Rio Preto - Brazil
Total Affiliations: 3
Document type: Journal article
Source: Brazilian Journal of Medical and Biological Research; v. 42, n. 5, p. 397-403, MAY 2009.
Web of Science Citations: 8
Abstract

We evaluated genetic variants of apolipoprotein E (APOE HhaI) and their association with serum lipids in colorectal cancer (CRC), together with eating habits and personal history. Eight-seven adults with CRC and 73 controls were studied. APOE*2 (rs7412) and APOE*4 (rs429358) were identified by polymerase chain reaction-restriction fragment length polymorphism. APOE gene polymorphisms were similar in both groups, but the ε4/ε4 genotype (6%) was present only in controls. The patients had reduced levels (mean ± SD) of total cholesterol and low-density lipoprotein cholesterol fraction (180.4 ± 49.5 and 116.1 ± 43.1 mg/dL, respectively) compared to controls (204.2 ± 55.6, P = 0.135 and 134.7 ± 50.8 mg/dL; P = 0.330, respectively) indicating that they were not statistically significant after the Bonferroni correction. The APOE*4 allele was associated with lower levels of total cholesterol, low- and high-density lipoprotein cholesterol fraction and increased levels of very low-density lipoprotein cholesterol fraction and triglycerides only among patients (P = 0.014). There was a positive correlation between the altered lipid profile and increased body mass indexes in both groups (P < 0.010). Moreover, a higher rate of hypertension and overweight was observed in controls (P < 0.002). In conclusion, the presence of the ε4/ε4 genotype only in controls may be due to a protective effect against CRC. Lower lipid profile values among patients, even those on lipid-rich diets associated with the APOE*4 allele, suggest alterations in the lipid synthesis and metabolism pathways in CRC. (AU)